CURE ID Moves to Automated Data Collection in Light of COVID Pandemic - Drug Information Update

If your email program has trouble displaying this email, view it as a web page. CURE ID Moves to Automated Data Collection in Light of COVID Pandemic CDER has published a From Our Perspective on the Office of Medical Policy's Clinical Methodologies Group's (ClinMeth) recent HHS grant, which will allow ClinMeth to work with partners over the next two years to expand the open-access CURE ID platform of case reports to include anonymized electronic health record and registry data. The Critical Path Institute will serve as the partnership coordinating center for the grant. CURE ID allows health care providers to report new uses of existing drugs for 325 difficult-to-treat infectious diseases through a standardized and simple case report form from a website or mobile device.  With the grant, ClinMeth also plans to develop case report forms for patients with "long COVID" to upload their own information on what treatments they are receiving. The patient platform will also capture what treatment outcomes are most important to patients, which will help provide insights into treatment successes that may impact quality of life.  Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA